Bottom line
YBMN vs JEPRX: the short answer
YBMN (Defiance BMNR Option Income ETF) and JEPRX (JPMorgan Equity Premium Income Fund) are both etfs.
But JEPRX is far broader, holding 127 positions to 4 for YBMN, so beyond the top names it adds exposure YBMN doesn't have.
JEPRX is cheaper at 0.34% vs 0.85% — a difference of $51 a year per $10,000 invested.
Updated Nov 19, 2026
YBMN vs JEPRX side by side
| YBMN | JEPRX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Grayscale | J.P. Morgan |
| Category | Options & Covered-Call Income | Options & Covered-Call Income |
| Expense ratio | 0.85% | 0.34% |
| Annual cost per $10k | $85 | $34 |
| 10-yr cost on $10k (prospectus) | — | $431 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +8.0% |
| 5-yr return (annualized) | — | +9.4% |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +11.0% |
| Worst quarter | — | −17.5% |
| Net assets (fund) | $3.0M | $5.1B |
| Number of holdings | 4 | 127 |
| Portfolio turnover | — | 183% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
YBMN and JEPRX share none of their top holdings.
YBMN top 10
- Treasury Bill — 79.97%
- N/a — 7.12%
- N/a — -0.57%
- N/a — -11.79%
JEPRX top 10
- AbbVie, Inc. — 1.73%
- Howmet Aerospace, Inc. — 1.69%
- Johnson & Johnson — 1.66%
- Eaton Corp. plc — 1.63%
- Trane Technologies plc — 1.61%
- Lam Research Corp. — 1.56%
- NVIDIA Corp. — 1.52%
- Apple, Inc. — 1.52%
- Ross Stores, Inc. — 1.51%
- Alphabet, Inc. — 1.50%
FAQ
What is the difference between YBMN and JEPRX?
YBMN (Defiance BMNR Option Income ETF) and JEPRX (JPMorgan Equity Premium Income Fund) are both etfs. But JEPRX is far broader, holding 127 positions to 4 for YBMN, so beyond the top names it adds exposure YBMN doesn't have.
Which is cheaper, YBMN or JEPRX?
JEPRX has the lower expense ratio (0.34%).
Should I own both YBMN and JEPRX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.